Heparin, classification, side effects,safe dosage PDF

Preview

Summary

Heparin, classification, side effects,safe dosage,routes, purpose of treatment...

Description

PHARM-4-FUN

EST. TIME: 30 MIN (PER MEDICATION)

This activity provides you with the opportunity to create pertinent patient education on the pharmacological agents associated with the vSim activity. You will utilize this worksheet for each drug listed under the pharmacology are of the suggested reading section. STUDENT LEARNING OUTCOMES At the end of this activity, student will be able to: 1. 2.

Explain purpose for taking the identified pharmacological agents. Discuss pertinent patient education related to all the listed pharmacological agent.

ASSIGNMENT 1. 2. 3. 4. 5.

Log into thePoint and launch the assigned vSim, following all instructions posted on your learning management system (LMS). Review the information contained in the patient information. Review the smart sense links associated with the Pharmacological agents found in the suggested reading area. Use the smart sense link to complete the following “patient education” worksheet for each pharmacological agent listed in the Pharmacology are of the suggested reading section. Submit for review.

PATIENT EDUCATION WORKSHEET NAME OF MEDICATION, CLASSIFICATION, AND INCLUDE PROTOTYPE

MEDICATION: Heparin Sodium

CLASSIFICATION: Anticoagulan

PROTOTYPE: Heparin

SAFE DOSE OR DOSE RANGE, SAFE ROUTE Full-dose continuous IV infusion therapy for DVT or PE: Adults: Initially, 5,000 units (or 80 units/kg) by IV bolus; then 20,000 to 40,000 units/day (or 18 units/kg/hour) by IV infusion with pump. Titrate hourly rate based on aPTT results (every 4 to 6 hours in the early stages of treatment). Full-dose sub cut therapy for DVT or Pe Adults: Initially, 5,000 units IV bolus and 10,000 to 20,000 units in a concentrated solution sub cut; then 8,000 to 10,000 units sub cut every 8 hours or 15,000 to 20,000 units in a concentrated solution sub cut every 12 hours. Full-dose intermittent anticoagulation IV therapy for DVT or PE Adults: Initially, 10,000 units by IV bolus; then 5,000 to 10,000 units (or 50 to 70 units/kg) IV every 4 to 6 hours titrated according to aPTT. Fixed low-dose therapy for prevention of venous thrombosis, PE, embolism associated with atrial fibrillation, and postoperative DVT Adults: 5,000 units sub cut every 12 hours. In surgical patients, give first dose 2 hours before procedure; then 5,000 units sub cut every 8 to 12 hours for 5 to 7 days or until patient can walk PURPOSE FOR TAKING THIS MEDICATION Drug therapy for DVT or PE. It accelerates formation of antithrombin III–thrombin complex and deactivates thrombin, preventing conversion of fibrinogen to fibrin.

PATIENT EDUCATION WHILE TAKING THIS MEDICATION Instruct patient and family to report all adverse reactions. Advise patient and family to watch for signs and symptoms of bleeding or bruising and to notify prescriber immediately if any occur. Tell patient to avoid OTC drugs containing aspirin, other salicylates, or drugs that may interact with heparin unless ordered by prescriber. Advise patient to consult prescriber before starting herbal therapy; many herbs have anticoagulant, antiplatelet, or fibrinolytic properties....